课题基金 / 基金详情

The Fe(II and 2OG dependent dioxygenase Jmjd6 in Hydra: Highly conserved in all animals, essential in vertebrates - does it have an evolutionary conserved function

The Fe(II and 2OG dependent dioxygenase Jmjd6 in Hydra: Highly conserved in all animals, essential in vertebrates - does it have an evolutionary conserved function
水螅中的 Fe(II 和 2OG 依赖性双加氧酶 Jmjd6:在所有动物中高度保守,在脊椎动物中必不可少 - 它是否具有进化保守功能
批准号:
471245357
负责人:
Professorin Dr. Angelika Böttger
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
--
资助国家:
德国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Professorin Dr. Angelika Böttger的其他基金

相似基金

相关文献

中文摘要
翻译
Fe(II)和2-酮戊二酸依赖性双加氧酶的JmjC结构域家族在人类中包含约60个成员。它们参与羟化底物如蛋白质或核酸;并参与逆转精氨酸或赖氨酸N-甲基化,将其分为羟化酶和脱甲基酶。由于它们的活性取决于氧张力和三羧酸中间体,它们能够将蛋白质和核酸修饰与环境条件联系起来,这对于一些动态表观遗传修饰很重要。jmjd 6是该家族的一员,对脊椎动物胚胎发育和致癌机制具有重要的生物学意义。尽管Jmjd 6对小鼠和斑马鱼的发育至关重要,但人类Jmjd 6的分子功能还没有得到充分的理解,并且部分地进行了有争议的讨论。在早期后生动物中,几乎没有关于Jmjd 6的生化和生理作用的信息。从水螅到人类的Jmjd 6序列非常强的保守性表明,有一个保守的功能,必须被发现。因此,我们建议在早期后生动物水螅,这是一个理想的模式生物联合收割机生化与发育研究的特点Jmjd 6。使用针对Hydra-Jmjd 6的小鼠单克隆抗体,我们将鉴定与Hydra-Jmjd 6相互作用的蛋白质和蛋白质结构域,并将其与人类Jmjd 6相互作用组进行比较。我们将进行X射线结构分析,以了解Jmjd 6的3-D结构的演变,并确定其对已鉴定底物的酶活性。此外,我们正计划研究缺氧和营养对mRNA和蛋白质水平以及Jmjd 6亚核分布的影响,我们将分析Jmjd 6在水螅发育过程中的作用,如再生和出芽。将采用转基因系的表征和泛特异性Fe(II)和2 OG依赖性双加氧酶抑制剂、Jmjd 6特异性抑制剂和siRNA的应用。使用载体pHyVec 12产生Jmjd 6敲低Hydra-lines的第二敲低方法将对此进行补充。我们希望这些研究将揭示Jmjd 6在人类中的分子和生物学作用。
英文摘要
The JmjC-domain family of Fe(II) and 2-oxoglutarate dependent dioxygenases contains about 60 members in humans. They are involved in hydroxylating substrates such as proteins or nucleic acids; and in reversing arginine or lysine N-methylations dividing them in hydroxylases and demethylases. As their activity depends on oxygen tension and tricarboxylic acid intermediates they are able to link protein and nucleic acid modifications with environmental conditions and this is important for some dynamic epigenetic modifications. Jmjd6 is a member of this family with great biological importance for vertebrate embryonic development and oncogenic mechanisms. Despite the fact that Jmjd6 is essential for mouse and zebrafish development the molecular function of human Jmjd6 is insufficiently understood and in parts controversially discussed. In early metazoans there is almost no information about the biochemical and physiological roles of Jmjd6. The remarkably strong sequence conservation of Jmjd6 from Hydra to humans indicates that there is a conserved function that has to be uncovered. We therefore suggest to characterize Jmjd6 in the early metazoan Hydra, which is an ideal model organism to combine biochemical with developmental studies. Using mouse monoclonal antibodies against Hydra-Jmjd6 we will identify proteins and protein domains that interact with Hydra-Jmjd6 and compare those with the human Jmjd6 interactome. We will carry out X-ray structural analysis to understand the evolution of the 3-D-structure of Jmjd6 and define its enzymatic activity towards the identified substrates. In addition, we are planning to study the effects of hypoxia and nutrition on mRNA- and protein levels as well as on the subnuclear distribution of Jmjd6, and we will analyze the role of Jmjd6 for Hydra developmental processes such as regeneration and budding. Characterization of transgenic lines and application of pan-specific Fe(II)- and 2OG dependent dioxygenase inhibitors, Jmjd6 specific inhibitors and siRNAs will be employed. A second knockdown approach generating Jmjd6 knockdown Hydra-lines using the vector pHyVec12 will complement this. We expect that these investigations will shed light on the molecular and biological roles of Jmjd6 in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The molecular mechanism of tissue boundary formation in animals
The physiological function of the Fe(II) and 2-oxo-glutarate dependent dioxygenase Jmjd6 in C. elegans
Molecular Mechanisms of apoptosis in Hydra
The role of the lysine-5-hydroxylase Jmjd6 for splicing
国内基金
海外基金
基于生境成像与深度学习联合临床特征构建II型卵巢癌术前淋巴结转移预测模型的研究
鸡软骨非变性II型胶原高效制备和靶向递送的关键技术开发与应用示范
青蒿琥酯协同TROP2/线粒体级联靶向的NIR-II多模态诊疗用于晚期TNBC精准诊断与治疗的机制研究
  • 批准号:
    2026JJ30126
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    杨沙
  • 依托单位:
苏合颗粒治疗慢性萎缩性胃炎的临床(II期)评价关键技术研究